Domus Diagnostics, Inc

Domus is developing affordable and accurate respiratory disease home testing for everyone, everywhere.

Founded 2021 5 employees Grant Total: $2.40M Biotechnology, Health Care

Domus Diagnostics, Inc is a biotechnology and health care startup founded in 2021. The company's slogan emphasizes its commitment to developing affordable and accurate respiratory disease home testing for everyone, everywhere. Domus Diagnostics is focused on creating infectious disease diagnostic tests that are not only affordable but also user-friendly, accurate, and rapid, addressing the needs raised by current and future public health crises. The startup received a significant investment of $2.40M in the form of a grant on 24 May 2023. The funding came from the National Institutes of Health, showcasing the recognition and support from a major player in healthcare research and development. This investment indicates confidence in Domus Diagnostics' potential to make a meaningful impact in the diagnostics and healthcare industry. Domus Diagnostics' focus on making respiratory disease testing accessible and accurate for individuals everywhere aligns with the growing demand for at-home healthcare solutions. With the support of the National Institutes of Health and their strong emphasis on user-friendly testing, Domus Diagnostics, Inc. appears to be well-positioned to address critical healthcare needs and potentially disrupt the diagnostics industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$2.40M	1	National Institutes of Health	24 May 2023
Seed Round	Undisclosed	1	Bantam Group	01 Jan 2023

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

$2.40M

National Institutes of Health

24 May 2023

Seed Round

Undisclosed

Bantam Group

01 Jan 2023

FAQ About Domus Diagnostics, Inc

Domus is developing affordable and accurate respiratory disease home testing for everyone, everywhere.

Domus Diagnostics, Inc was founded in 2021.

Domus Diagnostics, Inc operates in Biotechnology and Health Care. Its work centres on respiratory disease, home testing, diagnostic tests and infectious disease.

Domus Diagnostics, Inc has approximately 5 employees.

Domus Diagnostics, Inc has completed 2 funding rounds, raising a total of $2.40M. The latest funding stage is Grant.

Top alternatives and competitors to Domus Diagnostics, Inc include Pathnostics - A Diagnostics Solutions Company, Rapid Bio, LLC., Xagenic, Senzo Health, Arrow Dx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Domus Diagnostics, Inc and Pathnostics - A Diagnostics Solutions Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Domus Diagnostics, Inc

Funding Rounds & Investors (2)

Domus Diagnostics, Inc Alternatives & Competitors

FAQ About Domus Diagnostics, Inc